DI BIASE, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 18.324
EU - Europa 16.870
AS - Asia 14.097
SA - Sud America 2.677
Continente sconosciuto - Info sul continente non disponibili 1.036
AF - Africa 193
OC - Oceania 16
Totale 53.213
Nazione #
US - Stati Uniti d'America 17.988
CN - Cina 6.016
IE - Irlanda 5.281
UA - Ucraina 4.493
SG - Singapore 3.452
RU - Federazione Russa 2.570
BR - Brasile 2.234
SE - Svezia 1.694
HK - Hong Kong 1.487
VN - Vietnam 906
FI - Finlandia 842
TR - Turchia 839
IN - India 779
FR - Francia 620
DE - Germania 380
IT - Italia 361
GB - Regno Unito 284
AR - Argentina 179
CA - Canada 139
BD - Bangladesh 127
MX - Messico 110
EU - Europa 85
IQ - Iraq 77
EC - Ecuador 74
ID - Indonesia 68
AT - Austria 65
ZA - Sudafrica 61
PL - Polonia 56
CO - Colombia 55
PK - Pakistan 44
RO - Romania 43
JP - Giappone 41
MA - Marocco 36
UZ - Uzbekistan 34
NL - Olanda 32
SA - Arabia Saudita 32
VE - Venezuela 32
CL - Cile 30
PY - Paraguay 30
BE - Belgio 28
TN - Tunisia 26
ES - Italia 25
PH - Filippine 20
EG - Egitto 18
JO - Giordania 18
PE - Perù 18
CR - Costa Rica 17
JM - Giamaica 16
AU - Australia 14
DZ - Algeria 14
UY - Uruguay 14
AE - Emirati Arabi Uniti 13
NP - Nepal 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 12
IL - Israele 12
DO - Repubblica Dominicana 11
IR - Iran 11
KE - Kenya 11
KZ - Kazakistan 11
OM - Oman 11
PT - Portogallo 10
TH - Thailandia 10
GR - Grecia 9
HN - Honduras 9
BO - Bolivia 8
KR - Corea 8
MY - Malesia 8
PS - Palestinian Territory 8
BG - Bulgaria 7
LB - Libano 7
AL - Albania 6
ET - Etiopia 6
LT - Lituania 6
PA - Panama 6
BH - Bahrain 5
CH - Svizzera 5
CI - Costa d'Avorio 5
GT - Guatemala 5
HR - Croazia 5
HU - Ungheria 5
KW - Kuwait 5
RS - Serbia 5
TT - Trinidad e Tobago 5
DK - Danimarca 4
GA - Gabon 4
LV - Lettonia 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
GY - Guiana 3
KH - Cambogia 3
LU - Lussemburgo 3
MD - Moldavia 3
NG - Nigeria 3
NI - Nicaragua 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BB - Barbados 2
Totale 52.225
Città #
Dublin 5.273
Jacksonville 3.169
San Jose 3.015
Nanjing 1.693
Hong Kong 1.480
Singapore 1.405
Chandler 973
Ashburn 918
Dearborn 908
Nyköping 888
Wilmington 854
Beijing 781
Santa Clara 714
Nanchang 662
Council Bluffs 657
Princeton 637
San Mateo 554
Lauterbourg 545
Moscow 478
Dallas 407
Columbus 389
Shenyang 334
Ho Chi Minh City 323
Hebei 287
Tianjin 270
Kunming 245
Helsinki 206
Jiaxing 204
São Paulo 191
Hanoi 167
New York 154
Changsha 151
Ann Arbor 150
Hangzhou 149
Boardman 146
Des Moines 118
Jinan 107
Guangzhou 99
Hilden 92
Los Angeles 91
Changchun 75
Zhengzhou 75
Shanghai 73
Ningbo 71
Woodbridge 68
Dong Ket 67
Lanzhou 67
Stevenage 67
Nuremberg 66
The Dalles 62
Rio de Janeiro 61
Belo Horizonte 51
Mexico City 46
Warsaw 43
Norwalk 41
Porto Alegre 40
Curitiba 39
Taizhou 39
Timisoara 39
Frankfurt am Main 38
Haiphong 38
Toronto 36
Chicago 33
Orange 33
Tashkent 31
Brasília 30
San Francisco 30
Milan 29
Tokyo 29
Vienna 29
Baghdad 28
Biên Hòa 28
Campinas 28
Fuzhou 28
Da Nang 27
Brooklyn 26
Redwood City 26
Quito 25
Guayaquil 24
Wuhan 24
Montreal 23
Dhaka 22
Orem 22
Rome 22
Johannesburg 21
Manaus 21
Salvador 21
Thái Bình 20
Cape Town 19
Guarulhos 19
London 19
Atlanta 18
Boston 18
Chennai 18
Jinhua 18
Volta Redonda 18
Hanover 17
Hefei 17
Houston 17
Manchester 17
Totale 31.981
Nome #
A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality 174
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing 170
3-D Assessment of Myocardial Ablation Lesions using Ultrasound-guided Spectroscopic Photoacoustic Imaging 156
Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies 140
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study 139
2D and 3D TEE evaluation of an early Reopening of the LARIAT Epicardial left atrial appendage closure device. 132
[Takotsubo cardiomyopathy: current evidence from observational studies and pathophysiological background] 131
Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial 130
Ablation of atrial arrhythmias in heart failure 126
Statins do not reduce atrial fibrillation recurrence after pulmonary vein isolation in postmenopausal females 124
Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy 124
Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy the VISTA Randomized Multicenter Trial 124
Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSILOG Study 122
Ablation as First-Line Therapy for Atrial Fibrillation 122
EFFECT OF CATHETER ABLATION ON THE CLINICAL COURSE OF MIGRAINE IN ATRIAL FIBRILLATION PATIENTS WITH OR WITHOUT PRE-EXISTENT MIGRAINE: RESULTS FROM A PROSPECTIVE STUDY (CONFIRM) 122
Preferential Association of Biomarkers With Non-paroxysmal Atrial Fibrillation Indicates The Role of Inflammation in Persistence of the Arrhythmia 122
Left atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: A meta-analysis 122
Amiodarone increases the AF termination during ablation but reduces the long term success rate of patients undergoing ablation of long-standing persistent atrial fibrillation: preliminary results from the speculate study 121
Ablation for Atrial Fibrillation 120
Pulmonary vein antrum isolation, atrioventricular junction ablation, and antiarrhythmic drugs combined with direct current cardioversion: survival rates at 7 years follow-up 119
Mortality of Heart Failure Patients After Cardiac Resynchronization Therapy: Identification of Predictors 119
A Practical ECG Criterion to Unmask Left Accessory AV Connections in Patients With Subtle Preexcitation 119
Esophageal Capsule Endoscopy After Radiofrequency Catheter Ablation for Atrial Fibrillation Documented Higher Risk of Luminal Esophageal Damage With General Anesthesia as Compared With Conscious Sedation 118
Outcomes of Atrio-Esophageal Fistula Following Catheter Ablation of Atrial Fibrillation Treated With Esophageal Stent: a Case Series 118
Dynamic changes of QTc interval and prognostic significance in takotsubo (stress) cardiomyopathy 118
Aggressive Life-style Modifications Facilitate Arrhythmia-free Survival in Atrial Fibrillation Patients With Coexistent Metabolic Syndrome and Sleep Apnea Having Sporadic Recurrence Following First Ablation Procedure Sanghamitra Mohanty, Prasant Mohanty, Lui 117
Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites 117
Ventricular Tachycardia Ablation—For Whom, When, and How? 115
Impact of gender on outcomes after atrial fibrillation ablation 115
Ablating the Posterior Heart: Cardioesophageal Fistula Complicating Radiofrequency Ablation in the Coronary Sinus 115
Atrial fibrillation termination mode comparing three common ablation strategies for permanent atrial fibrillation: results from a randomized study. 114
Visual, tactile, and contact force feedback: which one is more important for catheter ablation? Results from an in vitro experimental study. 114
DOES TERMINATION OF ATRIAL FIBRILLATION DURING ABLATION OF LONG STANDING PERSISTENT ATRIAL FIBRILLATION PREDICT THE OUTCOME AT FOLLOW-UP? RESULTS FROM A PROSPECTIVE RANDOMIZED STUDY 114
Pulmonary Vein Isolation to Reduce Future Risk of Atrial Fibrillation in Patients Undergoing Typical Flutter Ablation: Results from a Randomized Pilot Study (REDUCE AF) 114
Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia 113
Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting 113
Cerebrovascular Complications Related to Atrial Fibrillation Ablation and Strategies for Periprocedural Stroke Prevention 112
Prognostic value of automatically detected early repolarization 112
Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the Remote Magnetic Navigation System and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series 111
Pacing site and bradycardia dependent retrograde conduction block over an atrioventricular accessory pathway 111
Chronicling the evolution of catheter ablation for atrial fibrillation and ventricular tachycardia. 111
[Catheter ablation of atrial fibrillation: an update from the most important trials]. 111
Hybrid strategies for Ablation of permanent AF as an Adjunct to PVI: implications of targeting AF NEST in sinus Rhythm and CFAE in AF. 110
Ablation for atrial fibrillation: termination of atrial fibrillation is not the endpoint. Contemporary debates and Controversies in Cardiac Electrophysiology, Part II 110
Safety and feasibility of levosimendan administration in Takotsubo Cardiomyopathy: A case series 110
Dabigratan Has a Higher Risk of Left Atrial Appendage Thrombus Formation in Patients With Af When Compared to Warfarin and Rivaroxaban 110
Intracardiac Echo Findings Post Atrial Fibrillation Ablation Are an Important Predictor of Late Pericardial Effusion 110
Robotic navigation for catheter ablation: benefits and challenges 110
Reply: A Prima Vista Ablation of Ventricular Tachycardia: Should We Abandon the Mapping of VT? 110
Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation. 109
Reverse remodelling induced by resynchronization therapy is associated to renin-angiotensin system activity improvement 109
Women have a Two-fold Higher Risk for Developing Cardiac Tamponade during AF Ablation Procedures: Results from a Multicenter International Survey in 27,249 Cases. 109
Catheter Ablation for Long-Standing Persistent Atrial Fibrillation 108
Pulmonary vein calcification by EBCT in patients with drug refractory nonvalular atrial fibrillation 107
Mechanical and electrical alternans in heart failure patients implanted with biventricular pacemakers. 107
Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads. 107
Silent Cerebral Events/Lesions Related to Atrial Fibrillation Ablation: A Clinical Review 107
Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium 107
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results 106
Remote magnetic navigation for atrial fibrillation ablation: is ‘As Good as Manual’ good enough 106
A novel technique to achieve better lesions in the coronary sinus: safety and feasibility. 106
[Catheter ablation as first-line therapy for atrial fibrillation: an analysis of available evidence]. 106
Prevalence and Management of Atrial Fibrillation in Middle-Aged/Older Athletes 106
Management of refractory atrial fibrillation post surgical ablation. 106
Zero Fluoroscopy Ablation of Atrial Fibrillation: A Safety and Feasibility Study 106
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 105
Metodo di mappaggio ed ablazione transcatetere di aritmie ventricolari attraverso il seno di Valsalva descrizione di due casi. 105
Ablation of an accessory pathway: endocardial and epicardial mapping 105
Ablation of atrial fibrillation under therapeutic INR reduces periprocedural complications: time to change the guidelines? 105
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial 105
Catheter ablation of ventricular arhhythmias with the remote magnetic navigation system and the 3.5 mm openirrigated magnetic catheter: results from a large single center series 104
Current and previous smoking increases mortality in patients on cardiac resynchronization therapy 104
Effect of periprocedural amiodarone on procedure outcome in longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: Results from a randomized study (SPECULATE) 104
Age-dependent impact of fluoroscopic radiation on the gender of off-spring: An international survey of cardiologists 104
Baseline Neutrophil/Lymphocyte Ratio Predicts Recurrences After Radiofrequency Catheter Ablation: Results From Prospective Study on Paroxysmal Atrial Fibrillation 104
Real Time Monitoring of Tip Electrode-Tissue Orientation and Contact Force: Optimizing Accuracy and Safety of Mapping and Ablation Procedures. 103
Safety and efficacy in females undergoing pulmonary vein isolation. 103
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation 103
How to Ablate Long-Standing, Persistent Atrial Fibrillation Using a Step-Wise Approach (The Natale Approach) 103
Role of intracardiac echocardiography in atrial fibrillation ablation 103
Influence of Hospital Characteristics and Operator Volume on Adverse Outcomes of Atrial Fibrillation Ablation 103
Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation 103
QTc interval prolongation and life-threatening arrhythmias during hospitalization in patients with COVID-19. Results from a multi-center prospective registry 103
Catheter-based Epicardial Closure of the Left Atrial Appendage 102
Assenza di eventi cardiaci maggiori in pazienti che presentano rimodellamento inverso e riduzione dei markers infiammatorii al follow-up dopo impianto di pacemaker biventricolare per scompenso cardiaco. 102
Long-term outcome of catheter ablation in atrial fibrillation patients with coexistent metabolic syndrome and obstructive sleep apnea: impact of repeat procedures versus lifestyle changes 102
Feasibility and Safety of Uninterrupted Rivaroxaban in Patients Undergoing Radiofrequency Ablation for Long Standing Persistent Atrial Fibrillation 102
Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction 102
Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants versus Warfarin for Stroke Prevention in Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Control Trials 102
Long-term safety and efficacy of supraventricular tachycardia ablation with a simplified approach 102
Pulmonary Vein Total Occlusion Following Catheter Ablation for Atrial Fibrillation: Clinical implications after long term follow up 101
OPEN IRRIGATION CATHETERS GENERATE HIGHER ESOPHAGEAL TISSUE TEMPERATURES THAN STANDARD 8MM TIP CATHETERS WHEN ABLATING WITHIN THE LEFT ATRIUM. 101
La crioablazione nel trattamento delle aritmie correlate a via accessoria antero e medio-settale: risultati acuti ed a lungo termine. 101
Novel association of polymorphic genetic variants with predictors of outcome of catheter ablation in atrial fibrillation: new directions from a prospective study (DECAF) 101
Atrial Fibrillation Ablation and Stroke 101
Pulmonary Vein Antrum Isolation in Patients With Paroxysmal Atrial Fibrillation: More Than a Decade of Follow-Up 101
Impact of uncontrolled hypertension on atrial fibrillation ablation outcome 101
Successful ablation of epicardial arrhythmias with cryoenergy after failed attempts with radiofrequency energy 100
AF termination as a procedural endpoint during ablation in long standing persistent atrial fibrillation 100
Utilità dell’introduttore lungo curva multipurpose nell’ablazione transcatetere mediante radiofrequenza di flutter atriale comune. 100
Totale 11.233
Categoria #
all - tutte 291.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 291.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.278 0 4 6 3 271 74 84 274 357 333 149 723
2022/20238.903 981 144 295 327 308 559 12 382 5.654 57 81 103
2023/2024815 149 49 48 34 74 216 30 36 15 11 9 144
2024/20257.419 301 40 94 105 83 1.071 628 396 2.824 641 489 747
2025/202612.398 639 729 1.554 2.624 273 420 2.614 1.310 908 806 283 238
2026/20271.353 164 1.189 0 0 0 0 0 0 0 0 0 0
Totale 53.213